Travere Therapeutics, Inc. - Common Stock (NQ:TVTX)
59.76
-0.52
(-0.86%)
Streaming Delayed Price
Updated: 10:59 AM EDT, Sep 23, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 288,346 |
| Open | 60.39 |
| Bid (Size) | 59.72 (500) |
| Ask (Size) | 59.81 (100) |
| Prev. Close | 60.28 |
| Today's Range | 59.57 - 60.89 |
| 52wk Range | 22.05 - 68.73 |
| Shares Outstanding | 60,717,176 |
| Dividend Yield | N/A |
Top News
More News
Travere Therapeutics Announces Planned Chief Executive Officer Transition
September 21, 2026
Performance
More News
Read More
Travere Therapeutics (TVTX) Q2 2026 Earnings Call Transcript ↗
August 11, 2026
Travere Therapeutics Q2 Earnings Call Highlights ↗
August 04, 2026
Frequently Asked Questions
Is Travere Therapeutics, Inc. - Common Stock publicly traded?
Yes, Travere Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Travere Therapeutics, Inc. - Common Stock trade on?
Travere Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Travere Therapeutics, Inc. - Common Stock?
The ticker symbol for Travere Therapeutics, Inc. - Common Stock is TVTX on the Nasdaq Stock Market
What is the current price of Travere Therapeutics, Inc. - Common Stock?
The current price of Travere Therapeutics, Inc. - Common Stock is 59.76
When was Travere Therapeutics, Inc. - Common Stock last traded?
The last trade of Travere Therapeutics, Inc. - Common Stock was at 09/23/26 10:59 AM ET
What is the market capitalization of Travere Therapeutics, Inc. - Common Stock?
The market capitalization of Travere Therapeutics, Inc. - Common Stock is 3.63B
How many shares of Travere Therapeutics, Inc. - Common Stock are outstanding?
Travere Therapeutics, Inc. - Common Stock has 4B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.